Table of Content

1 Immune Drugs Market Overview
1.1 Product Overview and Scope of Immune Drugs
1.2 Immune Drugs Segment by Type
1.2.1 Global Immune Drugs Market Value Comparison by Type (2024-2034)
1.2.2 Immune Boosting Drugs
1.2.3 Immunosuppressant Drugs
1.3 Immune Drugs Segment by Application
1.3.1 Global Immune Drugs Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Surgery Center
1.3.5 Others
1.4 Global Immune Drugs Market Size Estimates and Forecasts
1.4.1 Global Immune Drugs Revenue 2024-2034
1.4.2 Global Immune Drugs Sales 2024-2034
1.4.3 Global Immune Drugs Market Average Price (2024-2034)
1.5 Assumptions and Limitations
2 Immune Drugs Market Competition by Manufacturers
2.1 Global Immune Drugs Sales Market Share by Manufacturers (2024-2024)
2.2 Global Immune Drugs Revenue Market Share by Manufacturers (2024-2024)
2.3 Global Immune Drugs Average Price by Manufacturers (2024-2024)
2.4 Global Immune Drugs Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Immune Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Immune Drugs, Product Type & Application
2.7 Immune Drugs Market Competitive Situation and Trends
2.7.1 Immune Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Immune Drugs Players Market Share by Revenue
2.7.3 Global Immune Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Immune Drugs Retrospective Market Scenario by Region
3.1 Global Immune Drugs Market Size by Region: 2024 Versus 2022 Versus 2034
3.2 Global Immune Drugs Global Immune Drugs Sales by Region: 2024-2034
3.2.1 Global Immune Drugs Sales by Region: 2024-2024
3.2.2 Global Immune Drugs Sales by Region: 2024-2034
3.3 Global Immune Drugs Global Immune Drugs Revenue by Region: 2024-2034
3.3.1 Global Immune Drugs Revenue by Region: 2024-2024
3.3.2 Global Immune Drugs Revenue by Region: 2024-2034
3.4 North America Immune Drugs Market Facts & Figures by Country
3.4.1 North America Immune Drugs Market Size by Country: 2024 VS 2022 VS 2034
3.4.2 North America Immune Drugs Sales by Country (2024-2034)
3.4.3 North America Immune Drugs Revenue by Country (2024-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Immune Drugs Market Facts & Figures by Country
3.5.1 Europe Immune Drugs Market Size by Country: 2024 VS 2022 VS 2034
3.5.2 Europe Immune Drugs Sales by Country (2024-2034)
3.5.3 Europe Immune Drugs Revenue by Country (2024-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Immune Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Immune Drugs Market Size by Country: 2024 VS 2022 VS 2034
3.6.2 Asia Pacific Immune Drugs Sales by Country (2024-2034)
3.6.3 Asia Pacific Immune Drugs Revenue by Country (2024-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Immune Drugs Market Facts & Figures by Country
3.7.1 Latin America Immune Drugs Market Size by Country: 2024 VS 2022 VS 2034
3.7.2 Latin America Immune Drugs Sales by Country (2024-2034)
3.7.3 Latin America Immune Drugs Revenue by Country (2024-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Immune Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Immune Drugs Market Size by Country: 2024 VS 2022 VS 2034
3.8.2 Middle East and Africa Immune Drugs Sales by Country (2024-2034)
3.8.3 Middle East and Africa Immune Drugs Revenue by Country (2024-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Immune Drugs Sales by Type (2024-2034)
4.1.1 Global Immune Drugs Sales by Type (2024-2024)
4.1.2 Global Immune Drugs Sales by Type (2024-2034)
4.1.3 Global Immune Drugs Sales Market Share by Type (2024-2034)
4.2 Global Immune Drugs Revenue by Type (2024-2034)
4.2.1 Global Immune Drugs Revenue by Type (2024-2024)
4.2.2 Global Immune Drugs Revenue by Type (2024-2034)
4.2.3 Global Immune Drugs Revenue Market Share by Type (2024-2034)
4.3 Global Immune Drugs Price by Type (2024-2034)
5 Segment by Application
5.1 Global Immune Drugs Sales by Application (2024-2034)
5.1.1 Global Immune Drugs Sales by Application (2024-2024)
5.1.2 Global Immune Drugs Sales by Application (2024-2034)
5.1.3 Global Immune Drugs Sales Market Share by Application (2024-2034)
5.2 Global Immune Drugs Revenue by Application (2024-2034)
5.2.1 Global Immune Drugs Revenue by Application (2024-2024)
5.2.2 Global Immune Drugs Revenue by Application (2024-2034)
5.2.3 Global Immune Drugs Revenue Market Share by Application (2024-2034)
5.3 Global Immune Drugs Price by Application (2024-2034)
6 Key Companies Profiled
6.1 Antares Pharma, Inc.
6.1.1 Antares Pharma, Inc. Corporation Information
6.1.2 Antares Pharma, Inc. Description and Business Overview
6.1.3 Antares Pharma, Inc. Immune Drugs Sales, Revenue and Gross Margin (2024-2024)
6.1.4 Antares Pharma, Inc. Immune Drugs Product Portfolio
6.1.5 Antares Pharma, Inc. Recent Developments/Updates
6.2 UCB
6.2.1 UCB Corporation Information
6.2.2 UCB Description and Business Overview
6.2.3 UCB Immune Drugs Sales, Revenue and Gross Margin (2024-2024)
6.2.4 UCB Immune Drugs Product Portfolio
6.2.5 UCB Recent Developments/Updates
6.3 Incyte
6.3.1 Incyte Corporation Information
6.3.2 Incyte Description and Business Overview
6.3.3 Incyte Immune Drugs Sales, Revenue and Gross Margin (2024-2024)
6.3.4 Incyte Immune Drugs Product Portfolio
6.3.5 Incyte Recent Developments/Updates
6.4 GSK
6.4.1 GSK Corporation Information
6.4.2 GSK Description and Business Overview
6.4.3 GSK Immune Drugs Sales, Revenue and Gross Margin (2024-2024)
6.4.4 GSK Immune Drugs Product Portfolio
6.4.5 GSK Recent Developments/Updates
6.5 Takeda
6.5.1 Takeda Corporation Information
6.5.2 Takeda Description and Business Overview
6.5.3 Takeda Immune Drugs Sales, Revenue and Gross Margin (2024-2024)
6.5.4 Takeda Immune Drugs Product Portfolio
6.5.5 Takeda Recent Developments/Updates
6.6 3S Bio
6.6.1 3S Bio Corporation Information
6.6.2 3S Bio Description and Business Overview
6.6.3 3S Bio Immune Drugs Sales, Revenue and Gross Margin (2024-2024)
6.6.4 3S Bio Immune Drugs Product Portfolio
6.6.5 3S Bio Recent Developments/Updates
6.7 Horizo​​n Therapeutics
6.6.1 Horizo​​n Therapeutics Corporation Information
6.6.2 Horizo​​n Therapeutics Description and Business Overview
6.6.3 Horizo​​n Therapeutics Immune Drugs Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Horizo​​n Therapeutics Immune Drugs Product Portfolio
6.7.5 Horizo​​n Therapeutics Recent Developments/Updates
6.8 Bristol-Myers Squibb (BMS
6.8.1 Bristol-Myers Squibb (BMS Corporation Information
6.8.2 Bristol-Myers Squibb (BMS Description and Business Overview
6.8.3 Bristol-Myers Squibb (BMS Immune Drugs Sales, Revenue and Gross Margin (2024-2024)
6.8.4 Bristol-Myers Squibb (BMS Immune Drugs Product Portfolio
6.8.5 Bristol-Myers Squibb (BMS Recent Developments/Updates
6.9 Astellas
6.9.1 Astellas Corporation Information
6.9.2 Astellas Description and Business Overview
6.9.3 Astellas Immune Drugs Sales, Revenue and Gross Margin (2024-2024)
6.9.4 Astellas Immune Drugs Product Portfolio
6.9.5 Astellas Recent Developments/Updates
6.10 Eli Lilly
6.10.1 Eli Lilly Corporation Information
6.10.2 Eli Lilly Description and Business Overview
6.10.3 Eli Lilly Immune Drugs Sales, Revenue and Gross Margin (2024-2024)
6.10.4 Eli Lilly Immune Drugs Product Portfolio
6.10.5 Eli Lilly Recent Developments/Updates
6.11 Mitsubishi Tanabe Pharma
6.11.1 Mitsubishi Tanabe Pharma Corporation Information
6.11.2 Mitsubishi Tanabe Pharma Immune Drugs Description and Business Overview
6.11.3 Mitsubishi Tanabe Pharma Immune Drugs Sales, Revenue and Gross Margin (2024-2024)
6.11.4 Mitsubishi Tanabe Pharma Immune Drugs Product Portfolio
6.11.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
6.12 Biogen
6.12.1 Biogen Corporation Information
6.12.2 Biogen Immune Drugs Description and Business Overview
6.12.3 Biogen Immune Drugs Sales, Revenue and Gross Margin (2024-2024)
6.12.4 Biogen Immune Drugs Product Portfolio
6.12.5 Biogen Recent Developments/Updates
6.13 Pfizer
6.13.1 Pfizer Corporation Information
6.13.2 Pfizer Immune Drugs Description and Business Overview
6.13.3 Pfizer Immune Drugs Sales, Revenue and Gross Margin (2024-2024)
6.13.4 Pfizer Immune Drugs Product Portfolio
6.13.5 Pfizer Recent Developments/Updates
6.14 Sanofi
6.14.1 Sanofi Corporation Information
6.14.2 Sanofi Immune Drugs Description and Business Overview
6.14.3 Sanofi Immune Drugs Sales, Revenue and Gross Margin (2024-2024)
6.14.4 Sanofi Immune Drugs Product Portfolio
6.14.5 Sanofi Recent Developments/Updates
6.15 Roche
6.15.1 Roche Corporation Information
6.15.2 Roche Immune Drugs Description and Business Overview
6.15.3 Roche Immune Drugs Sales, Revenue and Gross Margin (2024-2024)
6.15.4 Roche Immune Drugs Product Portfolio
6.15.5 Roche Recent Developments/Updates
6.16 Novartis
6.16.1 Novartis Corporation Information
6.16.2 Novartis Immune Drugs Description and Business Overview
6.16.3 Novartis Immune Drugs Sales, Revenue and Gross Margin (2024-2024)
6.16.4 Novartis Immune Drugs Product Portfolio
6.16.5 Novartis Recent Developments/Updates
6.17 Johnson & Johnson (J&J)
6.17.1 Johnson & Johnson (J&J) Corporation Information
6.17.2 Johnson & Johnson (J&J) Immune Drugs Description and Business Overview
6.17.3 Johnson & Johnson (J&J) Immune Drugs Sales, Revenue and Gross Margin (2024-2024)
6.17.4 Johnson & Johnson (J&J) Immune Drugs Product Portfolio
6.17.5 Johnson & Johnson (J&J) Recent Developments/Updates
6.18 Amgen
6.18.1 Amgen Corporation Information
6.18.2 Amgen Immune Drugs Description and Business Overview
6.18.3 Amgen Immune Drugs Sales, Revenue and Gross Margin (2024-2024)
6.18.4 Amgen Immune Drugs Product Portfolio
6.18.5 Amgen Recent Developments/Updates
6.19 Abbvi
6.19.1 Abbvi Corporation Information
6.19.2 Abbvi Immune Drugs Description and Business Overview
6.19.3 Abbvi Immune Drugs Sales, Revenue and Gross Margin (2024-2024)
6.19.4 Abbvi Immune Drugs Product Portfolio
6.19.5 Abbvi Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Immune Drugs Industry Chain Analysis
7.2 Immune Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Immune Drugs Production Mode & Process
7.4 Immune Drugs Sales and Marketing
7.4.1 Immune Drugs Sales Channels
7.4.2 Immune Drugs Distributors
7.5 Immune Drugs Customers
8 Immune Drugs Market Dynamics
8.1 Immune Drugs Industry Trends
8.2 Immune Drugs Market Drivers
8.3 Immune Drugs Market Challenges
8.4 Immune Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Immune Drugs Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Immune Drugs Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Immune Drugs Market Competitive Situation by Manufacturers in 2022
Table 4. Global Immune Drugs Sales (K Units) of Key Manufacturers (2024-2024)
Table 5. Global Immune Drugs Sales Market Share by Manufacturers (2024-2024)
Table 6. Global Immune Drugs Revenue (US$ Million) by Manufacturers (2024-2024)
Table 7. Global Immune Drugs Revenue Share by Manufacturers (2024-2024)
Table 8. Global Market Immune Drugs Average Price (US$/Unit) of Key Manufacturers (2024-2024)
Table 9. Global Key Players of Immune Drugs, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Immune Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Immune Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Immune Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Immune Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune Drugs as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Immune Drugs Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 17. Global Immune Drugs Sales by Region (2024-2024) & (K Units)
Table 18. Global Immune Drugs Sales Market Share by Region (2024-2024)
Table 19. Global Immune Drugs Sales by Region (2024-2034) & (K Units)
Table 20. Global Immune Drugs Sales Market Share by Region (2024-2034)
Table 21. Global Immune Drugs Revenue by Region (2024-2024) & (US$ Million)
Table 22. Global Immune Drugs Revenue Market Share by Region (2024-2024)
Table 23. Global Immune Drugs Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Immune Drugs Revenue Market Share by Region (2024-2034)
Table 25. North America Immune Drugs Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 26. North America Immune Drugs Sales by Country (2024-2024) & (K Units)
Table 27. North America Immune Drugs Sales by Country (2024-2034) & (K Units)
Table 28. North America Immune Drugs Revenue by Country (2024-2024) & (US$ Million)
Table 29. North America Immune Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Immune Drugs Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Immune Drugs Sales by Country (2024-2024) & (K Units)
Table 32. Europe Immune Drugs Sales by Country (2024-2034) & (K Units)
Table 33. Europe Immune Drugs Revenue by Country (2024-2024) & (US$ Million)
Table 34. Europe Immune Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Immune Drugs Revenue by Region: 2024 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Immune Drugs Sales by Region (2024-2024) & (K Units)
Table 37. Asia Pacific Immune Drugs Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Immune Drugs Revenue by Region (2024-2024) & (US$ Million)
Table 39. Asia Pacific Immune Drugs Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Immune Drugs Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Immune Drugs Sales by Country (2024-2024) & (K Units)
Table 42. Latin America Immune Drugs Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Immune Drugs Revenue by Country (2024-2024) & (US$ Million)
Table 44. Latin America Immune Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Immune Drugs Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Immune Drugs Sales by Country (2024-2024) & (K Units)
Table 47. Middle East & Africa Immune Drugs Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Immune Drugs Revenue by Country (2024-2024) & (US$ Million)
Table 49. Middle East & Africa Immune Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Immune Drugs Sales (K Units) by Type (2024-2024)
Table 51. Global Immune Drugs Sales (K Units) by Type (2024-2034)
Table 52. Global Immune Drugs Sales Market Share by Type (2024-2024)
Table 53. Global Immune Drugs Sales Market Share by Type (2024-2034)
Table 54. Global Immune Drugs Revenue (US$ Million) by Type (2024-2024)
Table 55. Global Immune Drugs Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Immune Drugs Revenue Market Share by Type (2024-2024)
Table 57. Global Immune Drugs Revenue Market Share by Type (2024-2034)
Table 58. Global Immune Drugs Price (US$/Unit) by Type (2024-2024)
Table 59. Global Immune Drugs Price (US$/Unit) by Type (2024-2034)
Table 60. Global Immune Drugs Sales (K Units) by Application (2024-2024)
Table 61. Global Immune Drugs Sales (K Units) by Application (2024-2034)
Table 62. Global Immune Drugs Sales Market Share by Application (2024-2024)
Table 63. Global Immune Drugs Sales Market Share by Application (2024-2034)
Table 64. Global Immune Drugs Revenue (US$ Million) by Application (2024-2024)
Table 65. Global Immune Drugs Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Immune Drugs Revenue Market Share by Application (2024-2024)
Table 67. Global Immune Drugs Revenue Market Share by Application (2024-2034)
Table 68. Global Immune Drugs Price (US$/Unit) by Application (2024-2024)
Table 69. Global Immune Drugs Price (US$/Unit) by Application (2024-2034)
Table 70. Antares Pharma, Inc. Corporation Information
Table 71. Antares Pharma, Inc. Description and Business Overview
Table 72. Antares Pharma, Inc. Immune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 73. Antares Pharma, Inc. Immune Drugs Product
Table 74. Antares Pharma, Inc. Recent Developments/Updates
Table 75. UCB Corporation Information
Table 76. UCB Description and Business Overview
Table 77. UCB Immune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 78. UCB Immune Drugs Product
Table 79. UCB Recent Developments/Updates
Table 80. Incyte Corporation Information
Table 81. Incyte Description and Business Overview
Table 82. Incyte Immune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 83. Incyte Immune Drugs Product
Table 84. Incyte Recent Developments/Updates
Table 85. GSK Corporation Information
Table 86. GSK Description and Business Overview
Table 87. GSK Immune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 88. GSK Immune Drugs Product
Table 89. GSK Recent Developments/Updates
Table 90. Takeda Corporation Information
Table 91. Takeda Description and Business Overview
Table 92. Takeda Immune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 93. Takeda Immune Drugs Product
Table 94. Takeda Recent Developments/Updates
Table 95. 3S Bio Corporation Information
Table 96. 3S Bio Description and Business Overview
Table 97. 3S Bio Immune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 98. 3S Bio Immune Drugs Product
Table 99. 3S Bio Recent Developments/Updates
Table 100. Horizo​​n Therapeutics Corporation Information
Table 101. Horizo​​n Therapeutics Description and Business Overview
Table 102. Horizo​​n Therapeutics Immune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 103. Horizo​​n Therapeutics Immune Drugs Product
Table 104. Horizo​​n Therapeutics Recent Developments/Updates
Table 105. Bristol-Myers Squibb (BMS Corporation Information
Table 106. Bristol-Myers Squibb (BMS Description and Business Overview
Table 107. Bristol-Myers Squibb (BMS Immune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 108. Bristol-Myers Squibb (BMS Immune Drugs Product
Table 109. Bristol-Myers Squibb (BMS Recent Developments/Updates
Table 110. Astellas Corporation Information
Table 111. Astellas Description and Business Overview
Table 112. Astellas Immune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 113. Astellas Immune Drugs Product
Table 114. Astellas Recent Developments/Updates
Table 115. Eli Lilly Corporation Information
Table 116. Eli Lilly Description and Business Overview
Table 117. Eli Lilly Immune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 118. Eli Lilly Immune Drugs Product
Table 119. Eli Lilly Recent Developments/Updates
Table 120. Mitsubishi Tanabe Pharma Corporation Information
Table 121. Mitsubishi Tanabe Pharma Description and Business Overview
Table 122. Mitsubishi Tanabe Pharma Immune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 123. Mitsubishi Tanabe Pharma Immune Drugs Product
Table 124. Mitsubishi Tanabe Pharma Recent Developments/Updates
Table 125. Biogen Corporation Information
Table 126. Biogen Description and Business Overview
Table 127. Biogen Immune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 128. Biogen Immune Drugs Product
Table 129. Biogen Recent Developments/Updates
Table 130. Pfizer Corporation Information
Table 131. Pfizer Description and Business Overview
Table 132. Pfizer Immune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 133. Pfizer Immune Drugs Product
Table 134. Pfizer Recent Developments/Updates
Table 135. Sanofi Corporation Information
Table 136. Sanofi Description and Business Overview
Table 137. Sanofi Immune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 138. Sanofi Immune Drugs Product
Table 139. Sanofi Recent Developments/Updates
Table 140. Roche Corporation Information
Table 141. Roche Description and Business Overview
Table 142. Roche Immune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 143. Roche Immune Drugs Product
Table 144. Roche Recent Developments/Updates
Table 145. Novartis Corporation Information
Table 146. Novartis Description and Business Overview
Table 147. Novartis Immune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 148. Novartis Immune Drugs Product
Table 149. Novartis Recent Developments/Updates
Table 150. Johnson & Johnson (J&J) Corporation Information
Table 151. Johnson & Johnson (J&J) Description and Business Overview
Table 152. Johnson & Johnson (J&J) Immune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 153. Johnson & Johnson (J&J) Immune Drugs Product
Table 154. Johnson & Johnson (J&J) Recent Developments/Updates
Table 155. Amgen Corporation Information
Table 156. Amgen Description and Business Overview
Table 157. Amgen Immune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 158. Amgen Immune Drugs Product
Table 159. Amgen Recent Developments/Updates
Table 160. Abbvi Corporation Information
Table 161. Abbvi Description and Business Overview
Table 162. Abbvi Immune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 163. Abbvi Immune Drugs Product
Table 164. Abbvi Recent Developments/Updates
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Immune Drugs Distributors List
Table 168. Immune Drugs Customers List
Table 169. Immune Drugs Market Trends
Table 170. Immune Drugs Market Drivers
Table 171. Immune Drugs Market Challenges
Table 172. Immune Drugs Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Immune Drugs
Figure 2. Global Immune Drugs Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Immune Drugs Market Share by Type in 2022 & 2034
Figure 4. Immune Boosting Drugs Product Picture
Figure 5. Immunosuppressant Drugs Product Picture
Figure 6. Global Immune Drugs Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Immune Drugs Market Share by Application in 2022 & 2034
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Surgery Center
Figure 11. Others
Figure 12. Global Immune Drugs Revenue, (US$ Million), 2024 VS 2022 VS 2034
Figure 13. Global Immune Drugs Market Size (2024-2034) & (US$ Million)
Figure 14. Global Immune Drugs Sales (2024-2034) & (K Units)
Figure 15. Global Immune Drugs Average Price (US$/Unit) & (2024-2034)
Figure 16. Immune Drugs Report Years Considered
Figure 17. Immune Drugs Sales Share by Manufacturers in 2022
Figure 18. Global Immune Drugs Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Immune Drugs Players: Market Share by Revenue in 2022
Figure 20. Immune Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 21. Global Immune Drugs Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Figure 22. North America Immune Drugs Sales Market Share by Country (2024-2034)
Figure 23. North America Immune Drugs Revenue Market Share by Country (2024-2034)
Figure 24. United States Immune Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 25. Canada Immune Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 26. Europe Immune Drugs Sales Market Share by Country (2024-2034)
Figure 27. Europe Immune Drugs Revenue Market Share by Country (2024-2034)
Figure 28. Germany Immune Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 29. France Immune Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 30. U.K. Immune Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 31. Italy Immune Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 32. Russia Immune Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 33. Asia Pacific Immune Drugs Sales Market Share by Region (2024-2034)
Figure 34. Asia Pacific Immune Drugs Revenue Market Share by Region (2024-2034)
Figure 35. China Immune Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 36. Japan Immune Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 37. South Korea Immune Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 38. India Immune Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 39. Australia Immune Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 40. China Taiwan Immune Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 41. Southeast Asia Immune Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 42. Latin America Immune Drugs Sales Market Share by Country (2024-2034)
Figure 43. Latin America Immune Drugs Revenue Market Share by Country (2024-2034)
Figure 44. Mexico Immune Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 45. Brazil Immune Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 46. Argentina Immune Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 47. Middle East & Africa Immune Drugs Sales Market Share by Country (2024-2034)
Figure 48. Middle East & Africa Immune Drugs Revenue Market Share by Country (2024-2034)
Figure 49. Turkey Immune Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 50. Saudi Arabia Immune Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 51. UAE Immune Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 52. Global Sales Market Share of Immune Drugs by Type (2024-2034)
Figure 53. Global Revenue Market Share of Immune Drugs by Type (2024-2034)
Figure 54. Global Immune Drugs Price (US$/Unit) by Type (2024-2034)
Figure 55. Global Sales Market Share of Immune Drugs by Application (2024-2034)
Figure 56. Global Revenue Market Share of Immune Drugs by Application (2024-2034)
Figure 57. Global Immune Drugs Price (US$/Unit) by Application (2024-2034)
Figure 58. Immune Drugs Value Chain
Figure 59. Immune Drugs Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed